Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
23.70
-0.77 (-3.15%)
May 30, 2025, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 9.47 billion as of June 2, 2025. Its market cap has decreased by -32.99% in one year.
Market Cap
9.47B
Enterprise Value
10.70B
Revenue
177.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.70
Market Cap Chart
Since January 18, 2022, SHA:688062's market cap has decreased from 9.79B to 9.47B, a decrease of -3.27%. That is a compound annual growth rate of -0.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2025 | 9.47B | 17.33% |
Dec 31, 2024 | 8.07B | -38.21% |
Dec 29, 2023 | 13.06B | 126.23% |
Dec 30, 2022 | 5.77B | -41.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 362.72B |
Shenzhen Mindray Bio-Medical Electronics | 273.17B |
WuXi AppTec | 181.57B |
Zhangzhou Pientzehuang Pharmaceutical., | 123.11B |
Sichuan Biokin Pharmaceutical | 120.77B |
Aier Eye Hospital Group | 115.34B |
Shanghai United Imaging Healthcare | 112.70B |
Yunnan Baiyao Group Co.,Ltd | 100.78B |